These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 7503060)

  • 21. Painless subcutaneous erythropoietin (rHuEpo) injection--is it the panacea?
    Hörl WH
    Nephrol Dial Transplant; 1994; 9(9):1224-5. PubMed ID: 7816279
    [No Abstract]   [Full Text] [Related]  

  • 22. Infusion of total dose iron versus oral iron supplementation in ambulatory peritoneal dialysis patients: a prospective, cross-over trial.
    Ahsan N
    Adv Perit Dial; 2000; 16():80-4. PubMed ID: 11045266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. rHuEPO in the treatment of postpartum anemia: subcutaneous versus intravenous administration.
    Zimmermann R; Breymann C; Huch R; Huch A
    Clin Investig; 1994; 72(6 Suppl):S25-30. PubMed ID: 7950168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of C-reactive protein, reticulocyte haemoglobin content and inflammatory markers in iron and erythropoietin administration in dialysis patients.
    El-Khatib M; Duncan HJ; Kant KS
    Nephrology (Carlton); 2006 Oct; 11(5):400-4. PubMed ID: 17014552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The role of iron deficiency on the development of anemia in patients on regular dialysis therapy].
    Zadrazil J; Papajík T; Bachleda P; Budíková M; Novotný D; Scudla V
    Vnitr Lek; 1994 Jun; 40(6):362-6. PubMed ID: 8073646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Iron supplementation in renal anemia.
    Fishbane S
    Semin Nephrol; 2006 Jul; 26(4):319-24. PubMed ID: 16949471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous iron supplementation for the treatment of anaemia in pre-dialyzed chronic renal failure patients.
    Mircescu G; Gârneata L; Capusa C; Ursea N
    Nephrol Dial Transplant; 2006 Jan; 21(1):120-4. PubMed ID: 16144853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Iron therapy: overview and recommendations.
    Macdougall IC
    Przegl Lek; 1998; 55 Suppl 1():72. PubMed ID: 9857704
    [No Abstract]   [Full Text] [Related]  

  • 29. ITDI is the preferred treatment for iron supplementation in rHuEpo-treated anemic PD patients.
    Ahsan N
    Adv Perit Dial; 1998; 14():228-31. PubMed ID: 10649730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anemia in children with chronic kidney disease.
    Greenbaum LA
    Adv Chronic Kidney Dis; 2005 Oct; 12(4):385-96. PubMed ID: 16198278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Iron-replete hemodialysis patients do not require higher EPO dosages when converting from subcutaneous to intravenous administration: results of the Italian Study on Erythropoietin Converting (ISEC).
    Pizzarelli F; David S; Sala P; Icardi A; Casani A
    Am J Kidney Dis; 2006 Jun; 47(6):1027-35. PubMed ID: 16731298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How to save money for erythropoietin therapy by changing from 'roller coaster' to continuous iron supplementation.
    Canavese C; Grill A; De Costanzi E; Martina G; Buglione E; Valente D; David O; Saitta M; Maddalena E; Barbieri S; Fop F; Salomone M; Piccoli G
    Nephron; 1999; 81(3):362-3. PubMed ID: 10050100
    [No Abstract]   [Full Text] [Related]  

  • 33. Recombinant human erythropoietin in anemic patients on maintenance hemodialysis: comparison between intravenous and subcutaneous administration.
    Zehnder C; Blumberg A
    Nephron; 1991; 57(4):485-6. PubMed ID: 2046836
    [No Abstract]   [Full Text] [Related]  

  • 34. Intravenous administration of iron in epoetin-treated haemodialysis patients--which drugs, which regimen?
    Macdougall IC
    Nephrol Dial Transplant; 2000 Nov; 15(11):1743-5. PubMed ID: 11071957
    [No Abstract]   [Full Text] [Related]  

  • 35. Does intravenous erythropoietin lead to an immediate, transient increase in arterial blood pressure in dialysis patients?
    Touam M; Perez Oliva J; Zingraff J; Drüeke T
    Nephron; 1994; 67(2):240-1. PubMed ID: 8072618
    [No Abstract]   [Full Text] [Related]  

  • 36. [Optimum route for the administration of erythropoietin and iron. Effects of fractionation of small and large doses of erythropoietin].
    Arnáez-Vargas E; Faura J
    Arch Inst Biol Andina; 1970 Dec; 3(56):217-23. PubMed ID: 5526855
    [No Abstract]   [Full Text] [Related]  

  • 37. Do oral iron supplements have any role in dialysis patients?
    Mariani LH; Berns JS
    Semin Dial; 2011; 24(4):385-7. PubMed ID: 21801222
    [No Abstract]   [Full Text] [Related]  

  • 38. Pancreatic surgery in Jehovah's Witnesses: the role of perioperative erythropoietin and intravenous iron.
    Pozza E; Ascanelli S; Bardella E; Carcoforo P; Turini A; Navarra G
    Surgery; 2001 Jan; 129(1):120. PubMed ID: 11150046
    [No Abstract]   [Full Text] [Related]  

  • 39. Erythropoietin and autologous blood donation.
    Hennigan T; Hocken D
    Lancet; 1989 Nov; 2(8672):1153-4. PubMed ID: 2572869
    [No Abstract]   [Full Text] [Related]  

  • 40. Correction of the anemia of epidermolysis bullosa with intravenous iron and erythropoietin.
    Fridge JL; Vichinsky EP
    J Pediatr; 1998 May; 132(5):871-3. PubMed ID: 9602203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.